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Abstract
Background
The first 1,000 days of life, i.e., from conception to age 2 years, could be a critical period for
cardiovascular health. Increased carotid intima-media thickness (CIMT) is a surrogate
marker of atherosclerosis. We performed a systematic review with meta-analyses to assess
(1) the relationship between exposures or interventions in the first 1,000 days of life and
CIMT in infants, children, and adolescents; and (2) the CIMT measurement methods.
Methods and findings
Systematic searches of Medical Literature Analysis and Retrieval System Online (MED-
LINE), Excerpta Medica database (EMBASE), and Cochrane Central Register of Controlled
Trials (CENTRAL) were performed from inception to March 2019. Observational and inter-
ventional studies evaluating factors at the individual, familial, or environmental levels, for
instance, size at birth, gestational age, breastfeeding, mode of conception, gestational dia-
betes, or smoking, were included. Quality was evaluated based on study methodological
validity (adjusted Newcastle–Ottawa Scale if observational; Cochrane collaboration risk of
bias tool if interventional) and CIMT measurement reliability. Estimates from bivariate or par-
tial associations that were least adjusted for sex were used for pooling data across studies,
when appropriate, using random-effects meta-analyses. The research protocol was pub-
lished and registered on the International Prospective Register of Systematic Reviews
(PROSPERO; CRD42017075169). Of 6,221 reports screened, 50 full-text articles from 36
studies (34 observational, 2 interventional) totaling 7,977 participants (0 to 18 years at CIMT
assessment) were retained. Children born small for gestational age had increased CIMT (16
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studies, 2,570 participants, pooled standardized mean difference (SMD): 0.40 (95% confi-
dence interval (CI): 0.15 to 0.64, p: 0.001), I2: 83%). When restricted to studies of higher
quality of CIMT measurement, this relationship was stronger (3 studies, 461 participants,
pooled SMD: 0.64 (95% CI: 0.09 to 1.19, p: 0.024), I2: 86%). Only 1 study evaluating small
size for gestational age was rated as high quality for all methodological domains. Children
conceived through assisted reproductive technologies (ART) (3 studies, 323 participants,
pooled SMD: 0.78 (95% CI: −0.20 to 1.75, p: 0.120), I2: 94%) or exposed to maternal smok-
ing during pregnancy (3 studies, 909 participants, pooled SMD: 0.12 (95% CI: −0.06 to 0.30,
p: 0.205), I2: 0%) had increased CIMT, but the imprecision around the estimates was high.
None of the studies evaluating these 2 factors was rated as high quality for all methodologi-
cal domains. Two studies evaluating the effect of nutritional interventions starting at birth did
not show an effect on CIMT. Only 12 (33%) studies were at higher quality across all domains
of CIMT reliability. The degree of confidence in results is limited by the low number of high-
quality studies, the relatively small sample sizes, and the high between-study heterogeneity.
Conclusions
In our meta-analyses, we found several risk factors in the first 1,000 days of life that may be
associated with increased CIMT during childhood. Small size for gestational age had the
most consistent relationship with increased CIMT. The associations with conception through
ART or with smoking during pregnancy were not statistically significant, with a high impreci-
sion around the estimates. Due to the large uncertainty in effect sizes and the limited quality
of CIMT measurements, further high-quality studies are needed to justify intervention for pri-
mordial prevention of cardiovascular disease (CVD).
Author summary
Why was this study done?
• Exposure to adverse experiences in the first 1,000 days of life, i.e., from conception to
age 2 years, may determine adaptative changes in the blood vessel walls and increased
carotid intima-media thickness (CIMT) in infants, children, and adolescents. This
implies carotid arteries with thicker walls that may be due to changes in blood flow and
pressure or other factors related to the process of atherosclerosis.
What did the researchers do and find?
• We performed a systematic review of published studies with meta-analyses and included
36 studies, involving 7,977 participants between 0 and 18 years at CIMT assessment.
• Risk factors in the first 1,000 days of life, particularly poor fetal growth, are associated
with increased CIMT in infants, children, and adolescents.
• There is scarce evidence from interventional studies beginning in the first 1,000 days,
and none was shown to prevent or improve vascular remodeling in children.
• CIMT measurement protocols in children are heterogeneous and often poorly reported.
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What do these findings mean?
• From a public health perspective, acting early in life by preventing risk factors such as
poor fetal growth could help maintain a low cardiovascular risk over the life course.
• Assessing vascular structure and function in children is important to better characterize
lifetime risk trajectories and tailor primordial prevention of cardiovascular disease
(CVD). Primordial prevention aims to prevent the development of risk factors instead
of treating them.
• From a clinical standpoint, promotion of a healthy lifestyle is important at any age, and
screening of postnatal cardiovascular risk factors, targeted at children exposed to risk
factors in the first 1,000 days of life, may be warranted.
• A widely accepted standardized CIMT measurement protocol in children is needed.
Introduction
Background
Within a Developmental Origins of Health and Disease (DOHaD) framework, the first 1,000
days of life, i.e., the period from conception to age 2 years, is regarded as a critical period for
long-term cardiovascular health [1]. Evidence suggests that adaptations in body structure and
function during development, as a response to cues from the environment, for instance, assis-
ted reproductive technologies (ART) for conception [2], undernutrition, or environmental
pollutants [1], could increase the risk for cardiovascular disease (CVD). Indeed, several studies
showed that a low birth weight is associated with higher blood pressure [3] or diabetes risk [4],
as well as with cardiovascular mortality in adulthood [5].
Carotid intima-media thickness (CIMT) is a marker of CVD risk linked to pathways
that originate in the first 1,000 days of life. In adults, CIMT is predictive of heart attack
and stroke risk [6,7] and is also associated with prenatal risk factors, such as impaired fetal
growth and preterm birth [8,9]. Within a DOHaD perspective, these associations may be
explained by early life adaptative changes in the vascular phenotype [10], with lifelong effects
on the CVD risk. Nonetheless, in children, the evidence on increased CIMT after impaired
fetal growth or preterm birth is inconsistent [11–14]. Further, CVD risk is determined by a
combination of factors, at multiple levels, rather than a single factor [15]. A large range of early
life factors at the child, familial, or environmental levels needs to be explored to better under-
stand CIMT changes in children. To our knowledge, such a comprehensive overview is
lacking.
CIMT assessment in children can be challenging [16,17]. Several aspects related to the
ultrasound equipment [18–20], the site of measurement, or the edge detection approach may
influence the reliability of measurements [17,21]. Further, measurements in infants and young
children are challenging due to limited compliance, anatomic particularities, and a lack of rec-
ommendations tailored to this age group [16,22]. The comparability of studies is therefore lim-
ited, and the inconsistency in findings may be attributed, at least in part, to the heterogeneity
in CIMT measurement. An appraisal of the CIMT measurement methods in children is
needed to shed light on these limitations.
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We therefore aimed to perform a systematic review with meta-analyses to (1) assess the
relationship between exposures or interventions in the first 1,000 days of life and CIMT in
infants, children, and adolescents; and (2) critically appraise the CIMT measurement methods.
Methods
Protocol development and reporting
The protocol for this systematic review was registered on the International Prospective Regis-
ter of Systematic Reviews (PROSPERO; CRD42017075169) and published in full in a peer-
reviewed journal [23]. The reporting of this paper complies with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [24] (S1 PRISMA
Checklist) and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guide-
lines [25].
Eligibility criteria
Study designs. Observational and interventional studies with the following designs were
considered for inclusion: cohort, case–control, cross-sectional studies, randomized trials, non-
randomized controlled trials, and noncontrolled trials. Case reports, case series, opinion
papers, letters to the editor, comments, conference abstracts, policy papers, reviews and meta-
analyses, study protocols without baseline data, and animal studies were excluded.
Participants. We considered for inclusion studies in children from birth up to 18 years
old, including studies where participants were recruited pre-birth. Apparently, healthy chil-
dren and participants with clinical conditions relating to the first 1,000 days of life (e.g., prema-
turity) were included. Studies in children with rare or special conditions, such as congenital
heart diseases, or postnatal conditions conferring an increased risk of CVD, such as hyperten-
sion or diabetes, were not considered for inclusion. We aimed to make inferences to the gen-
eral population. Further, we assumed that there may be a different effect of DOHAD
exposures in these groups than in the general population, which should be evaluated
separately.
Exposures/Interventions. We considered for inclusion prenatal and postnatal exposures,
at the individual, familial, or environmental level, which reflected the developmental milieu of
the child and occurred between conception and age 24 months (i.e., first 1,000 days of life).
These included biological factors related to physiology, physiopathology, or epigenetics and
contextual factors related to socioeconomic status, behaviors, or environmental toxins. The
selection of exposures was informed by the review of Hanson and Gluckman [1] and Moore
and colleagues [26] and was conditioned by the timing of occurrence or ascertainment of
exposure, as appropriate. Exposures that started in the first 1,000 days of life, but continued in
later life, were included if they spanned up to 5 years of age. Likewise, periconceptional factors
that reflected the environment in which the baby was conceived and grew were included. For
interventional studies, we considered both pharmacological and non-pharmacological inter-
ventions, at the individual, familial, or environmental level, conducted in the first 1,000 days of
life. Specifically, eligible interventions had to start and end in the first 1,000 days of life or start
in the first 1,000 days of life and continue in later life no longer than child age 5 years.
Comparators. Where applicable, the use of a reference group without the exposure or
intervention of interest was sufficient for inclusion.
Outcome measures. The outcome was the intima-media thickness of the carotid artery
measured by ultrasonography from birth to 18 years of age.
Time frame and setting. There was no restriction by length of follow-up. There was no
restriction by type of setting.
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Language. Studies in English and French were considered for inclusion.
Search strategy
Systematic searches were conducted in the Medical Literature Analysis and Retrieval System
Online (MEDLINE) database, Excerpta Medica database (EMBASE), and Cochrane Central
Register of Controlled Trials (CENTRAL) from inception to 18 March 2019. The strategies for
the systematic searches included the 2 main concepts of this systematic review: (1) children
and adolescents; and (2) CIMT (detailed search strategies are available in S1 Table). Supple-
mentary searches consisted of (1) a manual search of reference lists and other reviews on the
topic; (2) forward citation tracking on Web of Science based on retrieved eligible reports; and
(3) personalized search queries in Google Scholar and trial registers. The full strategies are
available in S2 Table.
Study selection process
Following systematic searches in the databases, all retrieved reports were imported into Endnote
(version X8.1, Clarivate Analytics, London, United Kingdom), and duplicates were removed
according to the method of Bramer and colleagues [27]. Subsequently, reports were uploaded to
Covidence (www.covidence.org), a systematic review management platform. Two reviewers
performed study eligibility screening independently and in duplicate. Each reviewer screened
the reports in a 2-step approach: (1) based on titles and abstracts; and (2) based on full-text of
reports retained in the first step. The reviewers agreed on 94% of the titles and abstracts and on
84% of the full texts. Disagreements between reviewers were resolved by discussion, or, if neces-
sary, by a third reviewer. The investigator of 1 completed study (ClinicalTrials.gov identifier:
NCT02147457), with unpublished data on CIMT, was contacted by e-mail, but data could not
be made available due to technical and logistical issues when performing measurements.
Data extraction
Data were extracted independently and in duplicate by 2 reviewers using a standardized electronic
form in Microsoft Excel (version 2016, Microsoft Corporation, Redmond, United States of Amer-
ica). The data extraction process was piloted on a subset of articles, and a guide for extraction was
designed to minimize errors and enhance consistency between reviewers. We extracted informa-
tion about (1) study characteristics; (2) population characteristics; (3) CIMT definition and addi-
tional characteristics of the CIMT measurement methods; (4) characteristics of each exposure or
intervention type; and (5) adjusted and unadjusted association or effect estimates.
The quality of each study was evaluated independently by 2 reviewers using an adjusted ver-
sion of the Newcastle–Ottawa Scale for observational studies [28] and Cochrane collaboration
risk of bias tool for interventional studies [29,30] (S7 Table). The quality of the CIMT measure-
ment method was examined according to a predefined tool with 3 levels (higher, lower, and
unclear reliability). The complete tool and the algorithm of judgment are available in S3 Table.
Disagreements in extracted data between the 2 reviewers were resolved by discussion or
with the arbitration of a third reviewer. Essential missing information was searched by check-
ing additional references related to that study, such as the published research protocol. We
also attempted to contact authors of 2 studies by e-mail.
Data analysis
Analyses were conducted as prespecified in the study protocol [23]. Data transformations and
estimations were done according to recommendations and formulae provided in Borenstein
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and colleagues [31,32], the Cochrane Handbook for Systematic Reviews [29], Lipsey and col-
leagues [33], Rücker and colleagues [34], Wan and colleagues [35], Aloe and colleagues [36],
and Nieminen and colleagues [37]. The following data transformations were performed: (1)
when the mean was not available, it was estimated from the median [35]; (2) when standard
deviations were not available, they were estimated from the range or interquartile range [36],
standard errors [33], and confidence intervals (CIs) [29,33]; and (3) when standard errors
were not provided, they were calculated from CIs, p-values, and t-values [29,33]. To perform
meta-analyses, additional data simplifications were performed as follows: (1) if a study
reported on the same exposure or outcome type at multiple time points, the latest time point
was included in the analyses; (2) if a study reported on multiple exposed or reference sub-
groups, they were combined into 1 using formulae provided by the Cochrane collaboration in
case of means and standard deviations [29] or fixed-effect meta-analysis in case of association
estimates for each subgroup [32]; (3) if a study provided association estimates separately for
left and right CIMT or multiple sample groups, they were combined using fixed-effect meta-
analysis [32,34]; (4) if a study reported on both mean and maximum CIMT, mean CIMT was
included in the analyses; and (5) if multiple publications from the same study reported on the
same exposure type, the publication providing data on the longest follow-up, left and right
and/or mean thickness CIMT, or with the clearest reporting or highest sample size was used.
Standardized association measures were used to pool results across studies so that the com-
parison of different exposure types would be possible on the same scale. The standardized
mean difference (SMD) in CIMT between exposed and reference groups was used as the com-
mon association measure for binary exposure variables [31–33]. When means and standard
deviations for exposed and reference were not available or could not be estimated from other
statistics as reported above, SMD were estimated from the unstandardized regression coeffi-
cient and the full-sample standard deviation [33,38]. The correlation coefficient was used as
the common association measure for continuous exposure variables [32,33,36,37]. When the
correlation was not available, it was estimated from the regression coefficient and its standard
error or the unstandardized regression coefficient and the standard deviations of the exposure
and outcome variables [36,37]. If the reported association measures could not be transformed
to SMD or correlation coefficient, they were analyzed and reported separately. Estimates from
bivariate associations or partial associations that were least adjusted for sex were used for pool-
ing data across studies [39]. If at least 3 studies reported on the same exposure type, with a sim-
ilar definition, association estimates were pooled using the DerSimonian–Laird random-
effects model. As recommended by Amrhein and colleagues [40], together with more than 800
cosignatories of the initiative “Retire statistical significance,” and because we assessed multiple
associations, we interpreted the point estimate as the most compatible value of the observed
association. The uncertainty around the point estimate is comprised in the accompanying 95%
CI, which is reported along the corresponding p-value.
The heterogeneity was assessed using the Cochran Q test and I2 and tau2 statistics
[29,32,41]. I2 and tau2 are standard measures of heterogeneity in random-effect meta-analyses
that reflect the amount of true heterogeneity between studies, i.e., the variation in effect sizes
that is not due to sampling error. I2 is the percentage of variation in effect sizes attributable to
heterogeneity, ranging from 0% to 100%, with 0% indicating that all variation in effect sizes is
due to sampling error within studies and 100% indicating that all variation is due to true het-
erogeneity between studies [32]. Tau2 is used to assign study weights under the random-effects
model [32]. Sources of heterogeneity were explored using subgroup meta-analyses, meta-
regression, and sensitivity analyses. Publication bias was evaluated by the visual inspection of
funnel plots and, where appropriate, by Egger test. All statistical analyses were conducted with
Stata (version 16, StataCorp, Texas, USA) and Microsoft Excel (version 2019).
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Results
Study characteristics
The searches retrieved 8,338 reports (Fig 1). Following deduplication, titles and abstracts of
6,221 reports were screened, and 154 were selected for full-text screening. A total of 50 full-
text articles, pertaining to 36 studies, were eventually included. Details on study characteristics
and associated reports are presented in Table 1. Studies were conducted in Europe (n = 28),
Asia (n = 3), North America (n = 3), and Australia (n = 2). Some 23 studies were conducted in
healthcare facilities, 6 were community/population based, 4 included a mix of the aforemen-
tioned 2 settings, and 3 did not report any information about their participant recruitment
sites or sources. Exposures were evaluated in studies with a cohort (n = 22) or cross-sectional
(n = 14) design. Interventions were studied in 2 randomized controlled trials. All studies
Fig 1. Flow diagram showing the study selection process. CENTRAL, Cochrane Central Register of Controlled Trials; EMBASE, Excerpta Medica database;
MEDLINE, Medical Literature Analysis and Retrieval System Online.
https://doi.org/10.1371/journal.pmed.1003414.g001
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Table 1. Characteristics of included studies.
Author,
publication year
Country Design Setting N�
participants
Age at CIMT
assessment
Mean (SD),
CIMT, mm
Exposure/intervention categories at child
(1), family (2), or environmental (3) levels
Observational studies
Gale and
colleagues[42],
2006
UK cohort healthcare
facility
216 9 years right: 0.34
(0.06)
Diet and feeding practices (1), Fetal growth
(1), Postnatal growth (1), Maternal weight
and growth, nutrition, and physical activity
(2), Socioeconomic status (3), Tobacco
exposure (3)
Gale and
colleagues [43],
2008
UK cohort healthcare
facility
178 9 years right: 0.34
(0.06)
Maternal weight and growth, nutrition, and
physical activity (2)
Ayer and
colleagues [44],
2009a
Australia cohort healthcare
facility
405 8 years left and
right: 0.59
(0.07)
Fetal growth (1), Pregnancy-specific factors
(2), Tobacco exposure (3)
Ayer and
colleagues [45],
2009b
Australia cohort healthcare
facility
405 8 years left and
right: 0.59
(0.06)
Diet and feeding practices (1)
Ayer and
colleagues [46],
2011
Australia cohort healthcare
facility
405 8 years left and
right: 0.59
(0.1)
Tobacco exposure (3)
Skilton and
colleagues [47],
2012
Australia cohort healthcare
facility
363 8 years left and
right: 0.59
(0.06)
Fetal growth (1), Gestational age (1)
Skilton and
colleagues [48],
2013
Australia cohort healthcare
facility
395 8 years left or right:
0.77 (0.08)
Diet and feeding practices (1), Fetal growth
(1), Gestational age (1), Postnatal growth
(1), Socioeconomic status (3)
Crispi and
colleagues [11],
2010
Spain cohort healthcare
facility
200 2 to 6 years left and
right: 0.38
(0.11)
Fetal growth (1), Gestational age (1)
Rodriguez-Lopez
and colleagues
[49], 2016
Spain cohort healthcare
facility
202 4 to 5 years left and
right: 0.38
(0.03)
Diet and feeding practices (1), Fetal growth
(1), Gestational age, Other (1), Postnatal
growth (1), Pregnancy-specific factors (2),
Socioeconomic status (3), Tobacco exposure
(3)
Trevisanuto and
colleagues [50],
2010
Italy cohort unclear 38 3 to 5 years left: 0.51
(0.08); right:
0.51 (0.07)
Fetal growth (1)
Evelein and
colleagues [51],
2011
the Netherlands cohort community/
population
based
296 5 years right: 0.39
(0.04)
Diet and feeding practices (1)
Geerts and
colleagues [52],
2012
the Netherlands cohort community/
population
based
258 5 years right: 0.38
(0.03)
Tobacco exposure (3)
Evelein and
colleagues [53],
2013
the Netherlands cohort community/
population
based
323 5 years right: 0.39
(0.69)
Fetal growth (1), Postnatal growth (1)
Pluymen and
colleagues [54],
2017
the Netherlands cohort community/
population
based
413 5 years right: 0.39
(0.04)
Diet and feeding practices (1)
Atabek and
colleagues [55],
2011
Turkey cohort healthcare
facility
55 48 to 72 hours right: 0.31
(0.03)
Cardio-metabolic and inflammatory factors
(1), Fetal growth (1), Pregnancy-specific
factors (2)
Dratva and
colleagues [12],
2013
USA cohort community/
population
based
670 mean age: 11
years
right: 0.57
(0.04)
Fetal growth (1), Gestational age (1),
Pregnancy-specific factors (2)
Breton and
colleagues [56],
2016b
USA cohort community/
population
based
240 mean age: 11
years
N/S: 0.55
(0.05)
Epigenetics (1)
(Continued)
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Table 1. (Continued)
Author,
publication year
Country Design Setting N�
participants
Age at CIMT
assessment
Mean (SD),
CIMT, mm
Exposure/intervention categories at child
(1), family (2), or environmental (3) levels
Breton and
colleagues [57],
2016a
USA cohort community/
population
based
392 mean age: 11
years
left: 0.56
(0.05); right:
0.57 (0.04)
Epigenetics (1), Air pollution (3)
Schubert and
colleagues [58],
2013
Sweden cohort healthcare
facility
50 3 months N/S: 0.39
(0.12)
Gestational age (1)
Valenzuela-
Alcaraz and
colleagues [59],
2019
Spain cohort healthcare
facility
160 3 years left and
right: 0.49
(0.08)
Pregnancy-specific factors (2)
Lee and colleagues
[60], 2014
Germany cohort healthcare
facility
47 10 to 14 years left and
right: 0.45
(0.03)
Gestational age (1)
Morsing and
colleagues [61],
2014
Sweden cohort healthcare
facility
93 6 to 9 years N/S: 0.34
(0.06)
Fetal growth (1), Gestational age (1)
Stergiotou and
colleagues [62],
2014
Spain cohort healthcare
facility
201 0 to 1 week left and
right: 0.24
(0.05)
Cardio-metabolic and inflammatory factors
(1), Fetal growth (1)
Gruszfeld and
colleagues [63],
2015
Belgium,
Germany, Italy,
Poland, and Spain
cohort unclear 383 5 years left and
right: 0.4
(0.11)
Diet and feeding practices (1), Fetal growth
(1), Maternal weight and growth, nutrition,
and physical activity (2), Paternal factors
(2), Tobacco exposure (3)
Sebastiani and
colleagues [64],
2016
Spain cohort healthcare
facility
46 6 years left and
right: 0.35
(0.08)
Fetal growth (1)
Liu and colleagues
[65], 2017
Australia cohort community/
population
based
1,477 11 to 12 years right: 0.58
(0.05)
Socioeconomic status (3)
Mohlkert and
colleagues [66],
2017
Sweden cohort community/
population
based
235 6 years left: 0.38
(0.04); right:
0.38 (0.04)
Gestational age (1)
Tzschoppe and
colleagues [67],
2017
Germany cohort healthcare
facility
20 6 years left and
right: 0.38
(0.08)
Fetal growth (1)
Carreras-Badosa
and colleagues
[68], 2018
Spain cohort healthcare
facility
66 5 to 6 years right: 0.37
(0.03)
Maternal weight and growth, nutrition, and
physical activity (2)
Chen and
colleagues [69],
2019
Canada cohort healthcare
facility
119 1 year left and
right: 0.56
(0.06)
Cardio-metabolic and inflammatory factors
(1), Cardio-metabolic and inflammatory
factors (2)
Prins-Van Ginkel
and colleagues
[70], 2019
the Netherlands cohort other† 221 16 years left and
right: 0.47
(0.04)
Cardio-metabolic and inflammatory factors
(1)
Sebastiani and
colleagues [71],
2019
Spain cohort healthcare
facility
68 2 years left and
right: 0.3
(0.02)
Fetal growth (1)
Sundholm and
colleagues [72],
2019
Finland cohort other† 201 mean age: 6
years
left and
right: 0.36
(0.04)
Maternal weight and growth, nutrition, and
physical activity (2), Pregnancy-specific
factors (2)
Jouret and
colleagues [13],
2011
France cross-sectional healthcare
facility
113 mean age: 11
years
right: 0.46
(0.05)
Fetal growth (1)
(Continued)
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Table 1. (Continued)
Author,
publication year
Country Design Setting N�
participants
Age at CIMT
assessment
Mean (SD),
CIMT, mm
Exposure/intervention categories at child
(1), family (2), or environmental (3) levels
Scherrer and
colleagues [73],
2012
Switzerland cross-sectional other† 39 mean age: 11
years
left and
right: 0.39
(0.03)
Pregnancy-specific factors (2)
de Arriba and
colleagues [74],
2013
Spain‡ cross-sectional unclear 269 4 to 15 years N/S: 0.36
(0.08)
Fetal growth (1)
Maurice and
colleagues [75],
2014
Canada cross-sectional healthcare
facility
14 13 to 15 years right: 0.48
(0.05)
Fetal growth (1)
Xu and colleagues
[76], 2014
China cross-sectional healthcare
facility
124 3 to 7 years left: 0.39
(0.05)
Pregnancy-specific factors (2)
Putra and
colleagues [77],
2015
Indonesia cross-sectional community/
population
based
285 15 to 18 years N/S: 0.44
(0.07)
Diet and feeding practices (1)
Sodhi and
colleagues [78],
2015
India cross-sectional healthcare
facility
100 0 to 4 days left and
right: 0.42
(0.05)
Cardio-metabolic and inflammatory factors
(1), Fetal growth (1)
Ciccone and
colleagues [79],
2016
Italy cross-sectional healthcare
facility
30 3 to 5 years left: 0.51
(0.06); right:
0.52 (0.06)
Fetal growth (1), Gestational age (1)
Faienza and
colleagues [80],
2016
Italy cross-sectional healthcare
facility
52 mean age: 10
years
left and
right: 0.48
(0.06)
Fetal growth (1)
Olander and
colleagues [81],
2016
Finland cross-sectional healthcare
facility
174 5 to 184 hours left and
right: 0.17
(0.03)
Cardio-metabolic and inflammatory factors
(1), Fetal growth (1), Gestational age (1)
Dilli and
colleagues [82],
2017
Turkey cross-sectional healthcare
facility
60 0 to 48 hours left and
right: 0.32
(0.03)
Cardio-metabolic and inflammatory factors
(1), Fetal growth (1)
Stock and
colleagues [14]
2018
Austria and Italy cross-sectional community/
population
based
930 15 to 16 years left and
right: 0.38
(0.05)
Fetal growth (1), Gestational age (1)
Wilde and
colleagues [83],
2018
the Netherlands cross-sectional other† 162 6 to 8 years right: 0.38
(0.04)
Other (2)
Muñiz Fontán and
colleagues [84],
2019
Spain cross-sectional healthcare
facility
239 6 to 8 years left and
right: 0.43
(0.04)
Fetal growth (1)
Interventional studies
Ayer and
colleagues [45],
2009b
Australia randomized
controlled trial
healthcare
facility
405 8 years left and
right: 0.59
(0.06)
Diet and feeding practices (1)
Gruszfeld and
colleagues [63],
2015
Belgium,
Germany, Italy,
Poland, and Spain
randomized
controlled trial
unclear 383 5 years left and
right: 0.4
(0.11)
Diet and feeding practices (1)
Note: Studies reporting on both interventions and exposures were analyzed as randomized controlled trial for the data on interventions and as observational cohort for
the data on exposures (N = 2, namely Ayer and colleagues [45], 2009b and Gruszfeld and colleagues [63], 2015).
�N = number of participants with CIMT measurements introduced in the analyses.
†Mix of healthcare facility and community based.
‡Country of the first author.
CIMT, carotid intima-media thickness; N/S, not specified; SD, standard deviation; UK, United Kingdom; USA, United States of America.
https://doi.org/10.1371/journal.pmed.1003414.t001
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comprised girls and boys. Overall, the minimum age at CIMT assessment was 5 hours, and the
maximum age was 18 years.
CIMT measurement methods
Image acquisition methods were relatively uniform across studies, but image analysis methods
varied greatly (Tables 2 and S4). Measurements were performed on the common carotid artery
(CCA) in the majority of studies (92%). However, poor or missing information on key charac-
teristics of the CIMT measurement, namely the carotid wall, the method for edge detection
and analysis of the distance between interfaces, or quality control procedures were relatively
common. The segmental thickness (mean or maximum) and the type and number of sides
(right, left, or the mean of both) included in the CIMT calculation were among the main
sources of heterogeneity between studies. Several studies used multiple approaches for analy-
sis; thus, up to 3 different CIMT outcomes were reported in each publication. Only 12 (33.3%)
studies were at higher quality across all domains of CIMT reliability.
Risk factors at the child level
Child risk factors evaluated across studies included (1) small size for gestational age and other
fetal growth indicators, such as birth weight, length, head circumference; (2) prematurity; or
(3) duration of breastfeeding. The effect of interventions targeting the dietary intake of pro-
teins and polyunsaturated fatty acids after birth was also assessed.
CIMT was higher in children born small for gestational age (16 studies, 2,570 participants,
pooled SMD 0.40 (95% CI: 0.15 to 0.64, p: 0.001), I2: 83%) compared with those with an appro-
priate size at birth (Table 3; Fig 2A). The same relationship was found when analyses were
restricted to children born small and with a documented prenatal diagnosis of intrauterine
growth restriction (IUGR; 8 studies, 623 participants, pooled SMD 0.35 (95% CI: −0.06 to 0.77,
p: 0.097), I2: 77%). There was no clear association of prematurity with CIMT when data were
pooled across all studies (7 studies, 2,024 participants, pooled SMD 0.03 (95% CI: −0.17 to 0.22,
p: 0.805), I2: 50%) (Table 3; Fig 3A). However, small size for gestational age (3 studies, 461 par-
ticipants, pooled SMD: 0.64 (95% CI: 0.09 to 1.19, p: 0.024), I2: 86%) (Fig 2B) and prematurity
(3 studies, 736 participants, pooled SMD: 0.25 (95% CI: 0.02 to 0.48, p: 0.032), I2: 0%) (Fig 3B)
were consistently associated with higher CIMT, and the associations increased in magnitude
when restricted to studies of higher CIMT quality. Additionally, subgroup analyses showed that
CIMT was higher in infants than in older children exposed to these risk factors (Table 4). Meta-
analyses of other fetal growth indicators showed that CIMT tended to be lower with higher val-
ues of birth weight or length, but the magnitude of these relationships was low (Table 3).
Inconclusive evidence was found for breastfeeding. Four studies identified a lower CIMT
among children with a higher duration of breastfeeding (S5 Table). Two studies identified a
higher CIMT among children exclusively breastfed compared to exclusively formula fed (S5
Table). Meta-analysis was not possible due to very heterogenous comparisons across studies.
Two interventional studies on dietary interventions at the child level involved a total of 787
participants. In 1 study, a diet comprising a higher n-3 to n-6 fatty acids ratio from birth to age
5 years had no effect on CIMT (SMD 0 (95% CI: −0.20 to 0.20)) [45]. In the other study, non-
breastfed children on formulas with higher protein content during their first year of life had a
lower CIMT (SMD −0.21 (95% CI: −0.45 to 0.04)) compared to children on lower protein for-
mulas [63]. Scarce evidence, reported in 1 study, existed for other factors, such as cardio-meta-
bolic and inflammatory factors, for instance, blood pressure [81], cord blood cholesterol [55],
cortisol [69], and epigenetic changes, such as DNA methylation levels following exposure to
air pollution [56,57] (Tables 1 and S6).
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Table 2. CIMT measurement characteristics.
Author, publication
year
N
outcomes
Image acquisition Image analysis Reliability
Side Segment Wall Edge detection, analysis
of the distance between
interfaces
Cardiac
cycle phase
Wall
thickness
Acquisition
site
Analysis Reproducibility
assessment
Gale and colleagues
[41,43], 2006, 2008
1 right CCA far N/S, automatic over a
specific length
end
diastole
N/S higher higher higher
Ayer and colleagues
[44–46], 2009a,
2009b, 2011;
Skilton and
colleagues[47], 2012
1 left and
right
CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean higher higher higher
Skilton and
colleagues [85], 2013
1 left or
right
CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
maximum higher higher higher
Crispi and
colleagues [11,85],
2010, 2012
1 left and
right
CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean higher higher higher
Rodriguez-Lopez
and colleagues [49],
2016
1 left and
right
CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
N/S higher higher higher
Trevisanuto and
colleagues [50], 2010
2 left; right CCA far manual, point-to-point
measurements
N/S maximum higher lower higher
Evelein and
colleagues [51,53],
2011, 2013
Geerts and
colleagues [52], 2012
1 right CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
N/S higher higher higher
Pluymen and
colleagues [54], 2017
1 right CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
maximum higher higher higher
Atabek and
colleagues [55], 2011
1 right CCA far manual, point-to-point
measurements
N/S maximum higher lower unclear
Dratva and
colleagues [12], 2013
1 right CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean higher higher higher
Breton and
colleagues [57],
2016a
2 left; right CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
N/S higher higher higher
Breton and
colleagues [56],
2016b
1 N/S CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
N/S higher higher higher
Schubert and
colleagues [58], 2013
1 N/S CCA far N/S, automatic over a
specific length
end
diastole
mean higher higher higher
Valenzuela-Alcaraz
and colleagues
[59,86], 2013, 2019
2 left and
right
CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean;
maximum
higher higher higher
Lee and colleagues
[60], 2014
1 left and
right
CCA far automatic/
semiautomatic,
automatic over a specific
length
N/S mean higher higher higher
(Continued)
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Table 2. (Continued)
Author, publication
year
N
outcomes
Image acquisition Image analysis Reliability
Side Segment Wall Edge detection, analysis
of the distance between
interfaces
Cardiac
cycle phase
Wall
thickness
Acquisition
site
Analysis Reproducibility
assessment
Morsing and
colleagues [61], 2014
1 N/S CCA N/S manual, point-to-point
measurements
end
diastole
mean unclear lower unclear
Stergiotou and
colleagues [62], 2014
2 left and
right
CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean;
maximum
higher higher higher
Gruszfeld and
colleagues [63], 2015
1 left and
right
CCA far manual, point-to-point
measurements
end
diastole
mean higher lower lower
Sebastiani and
colleagues [64], 2016
1 left and
right
CCA far N/S, N/S end
diastole
N/S higher unclear higher
Liu and colleagues
[65], 2017
1 right CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
maximum higher higher higher
Mohlkert and
colleagues [66], 2017
2 left; right CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean higher higher unclear
Tzschoppe and
colleagues [67], 2017
1 left and
right
CCA N/S N/S, N/S N/S maximum unclear unclear unclear
Carreras-Badosa and
colleagues [68], 2018
1 right CCA N/S N/S, N/S N/S N/S unclear unclear higher
Chen and colleagues
[69], 2019
2 left and
right; left
or right
other� far N/S, automatic over a
specific length
N/S N/S;
maximum
unclear unclear unclear
Prins-Van Ginkel
and colleagues [70],
2019
1 left and
right
CCA N/S automatic/
semiautomatic,
automatic over a specific
length
end distole N/S unclear higher unclear
Sebastiani and
colleagues [71], 2019
1 left and
right
CCA far N/S, N/S end
diastole
N/S higher unclear higher
Sundholm and
colleagues [72], 2019
1 left and
right
CCA far manual, N/S end
diastole
N/S higher unclear higher
Jouret and
colleagues [13], 2011
1 right CCA N/S N/S, automatic over a
specific length
N/S N/S unclear unclear unclear
Scherrer and
colleagues [73,87],
2012
1 left and
right
CCA N/S automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean unclear higher higher
de Arriba and
colleagues [74], 2013
1 N/S CCA far N/S, N/S N/S maximum higher unclear unclear
Maurice and
colleagues [75], 2014
1 right CCA far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
N/S higher higher unclear
Xu and colleagues
[76], 2014
1 left CCA N/S N/S, N/S N/S N/S unclear unclear unclear
Putra and colleagues
[77], 2015
1 N/S N/S N/S N/S, N/S N/S N/S unclear unclear unclear
Sodhi and colleagues
[78], 2015
2 left and
right
CCA N/S manual, point-to-point
measurements
N/S mean;
maximum
unclear lower lower
(Continued)
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Risk factors at the family level
Family risk factors evaluated included (1) mode of conception; and (2) pregnancy complica-
tions, such as maternal diabetes. Children conceived through ART had, on average, an
increased CIMT (3 studies, 323 participants, pooled SMD 0.78 (95% CI: −0.20 to 1.75, p:
0.120), I2: 94%), but the imprecision around the estimate was high (Table 3; Fig 4A). There
was no clear association between maternal diabetes during pregnancy and offspring’s CIMT (3
studies, 658 participants, pooled SMD 0.08 (95% CI: −0.16 to 0.33, p: 0.495), I2: 17.1%)
(Table 3; Fig 4B). Scarce evidence, reported in 1 or 2 studies, existed for other risk factors, such
as preeclampsia or gestational hypertension [44,49], maternal physical activity level [42], vita-
min D levels [43,68], energy and macronutrient intakes during pregnancy [42], or paternal
BMI [63] (Tables 1 and S5 and S6).
Risk factors at the environmental level
Environmental risk factors evaluated included (1) exposure to tobacco (maternal, paternal,
and household); and (2) socioeconomic status (maternal, family, and neighborhood). Children
exposed to maternal smoking during pregnancy had, on average, an increased CIMT, but the
imprecision around the estimate was high (3 studies, 909 participants, pooled SMD 0.12 (95%
CI: −0.06 to 0.30, p: 0.205), I2: 0%) (Table 3; Fig 4C). Paternal smoking during pregnancy was
linked with increased CIMT in 1 study [49]. No difference in CIMT after exposure to passive
smoking in the first year of life was reported in 1 study [46]. Children with a lower socioeco-
nomic status tended to have a higher CIMT (S5 Table). Scarce evidence, reported in 1 study,
Table 2. (Continued)
Author, publication
year
N
outcomes
Image acquisition Image analysis Reliability
Side Segment Wall Edge detection, analysis
of the distance between
interfaces
Cardiac
cycle phase
Wall
thickness
Acquisition
site
Analysis Reproducibility
assessment
Ciccone and
colleagues [79], 2016
2 left; right CCA far N/S, N/S end
diastole
N/S higher unclear unclear
Faienza and
colleagues [80], 2016
1 left and
right
CCA N/S manual, point-to-point
measurements
end
diastole
N/S unclear lower higher
Olander and
colleagues [81], 2016
1 left and
right
CCA far manual, point-to-point
measurements
end
diastole
mean higher lower higher
Dilli and colleagues
[82], 2017
3 left; right;
left and
right
CCA far N/S, automatic over a
specific length
end
diastole
N/S higher higher higher
Stock and colleagues
[14], 2018
2 left and
right; left
or right
CCA far manual, point-to-point
measurements
N/S mean;
maximum
higher lower unclear
Wilde and
colleagues [83], 2018
1 right CCA far automatic/
semiautomatic,
automatic over a specific
length
diastole N/S higher higher higher
Muñiz Fontán and
colleagues [84], 2019
2 left and
right
CCA, ICA,
and CB
far automatic/
semiautomatic,
automatic over a specific
length
end
diastole
mean;
maximum
higher higher unclear
�Insufficient information to select a specific segment or combination of segments. Place of measurement was described as follows: “the carotid bulb, internal carotid
artery, and carotid bifurcation, and at least 2 cm below the bifurcation (i.e., into the common carotid artery) were imaged. CIMT was measured over a length of 1.5 cm
on each carotid artery.”
CB, carotid bulb; CCA, common carotid artery; ICA, internal carotid artery; N, number; N/S, not specified.
https://doi.org/10.1371/journal.pmed.1003414.t002
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existed for ambient air pollutants [57], such as nitrogen dioxide (NO2), ozone (O3), or particu-
late matter (PM10 and PM2.5) (Tables 1 and S6).
Discussion
Main findings
In this systematic review of 36 studies, involving 7,977 participants, multiple exposures at the
child, family, or environmental levels were evaluated. Small size for gestational age had the
most consistent association with increased CIMT. The magnitude of this association was
higher when restricted to studies with a higher quality of CIMT measurement. The associa-
tions with conception through ART or with maternal smoking during pregnancy were not sta-
tistically significant. Evidence from interventional studies was scarce and focused exclusively
on dietary interventions in the child, without showing an effect. CIMT measurement methods
varied across studies, and they were frequently poorly reported, with only 33% of studies rated
at higher quality across all domains of CIMT reliability.
Comparison with other studies
To the best of our knowledge, this is the first systematic review with such a multidimensional
view on risk factors in the first 1,000 days of life and CIMT in children. The underlying
Table 3. Summary of findings for each exposure type included in meta-analyses.
Category of
exposure
Type of exposure Level of comparison N
studies
N participants Association
measure
Association estimate Heterogeneity
Child level
Fetal growth Birth size for
gestational age
small� vs appropriate 16 2,570 (848 vs
1,722)
SMD 0.40 (95% CI: 0.15 to
0.64, p: 0.001)
I2: 83%, tau2: 0.18, p:
<0.001
small with IUGR
diagnosis vs appropriate
8 623 (176 vs
447)
SMD 0.35 (95% CI: −0.06 to
0.77, p: 0.097)
I2: 77%, tau2: 0.26, p:
<0.001
Birth weight range of values 7 1,445 Correlation −0.06 (95% CI: −0.19 to
0.08, p: 0.404)
I2: 82%, tau2: 0.02, p:
<0.001
Birth length range of values 3 424 Correlation −0.18 (95% CI: −0.36 to
0.00, p: 0.052)
I2: 64%, tau2: 0.02, p:
0.062
Birth head
circumference
range of values 3 329 Correlation 0.01 (95% CI: −0.40 to
0.42, p: 0.960)
I2: 93%, tau2: 0.14, p:
<0.001
Gestational age Gestational age preterm† vs term 7 2,024 (369 vs
1,655)
SMD 0.03 (95% CI: −0.17 to
0.22, p: 0.805)
I2: 50%, tau2: 0.03, p:
0.062
Family level
Pregnancy-
specific factors
Mode of conception ART‡ vs natural 3 323 (177 vs
146)
SMD 0.78 (95% CI: −0.20 to
1.75, p: 0.120)
I2: 94%, tau2: 0.69, p:
<0.001
Maternal diabetes in
pregnancy
yes§ vs no 3 658 (150 vs
508)
SMD 0.08 (95% CI: −0.16 to
0.33, p: 0.495)
I2: 17%, tau2: 0.01, p:
0.299
Environmental level
Tobacco exposure Maternal smoking in
pregnancy
yes vs no 3 909 (145 vs
734)
SMD 0.12 (95% CI: −0.06 to
0.30, p: 0.205)
I2: 0%, tau2: 0, p:
0.380
�Birth weight and/or length below the 10th percentile or 2 SDs below the mean, with or without a documented prenatal diagnosis of IUGR (fetal biometry or Doppler
velocimetry).
†Below 37 weeks of gestation, where specified.
‡In vitro fertilization or intracytoplasmic sperm injection.
§Gestational diabetes, where specified.
ART, assisted reproductive technologies; CI, confidence interval; IUGR, intrauterine growth restriction; N, number; p, p-value; SD, standard deviation; SMD,
standardized mean difference; vs, versus.
https://doi.org/10.1371/journal.pmed.1003414.t003
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mechanisms of CVD programming and atherosclerosis are multifactorial. Exposure to risk fac-
tors in critical periods of development may influence life course cardiovascular health trajecto-
ries through epigenetic changes [88] and cardio-metabolic factors [89] (e.g., growth patterns,
Fig 2. Association of small size for gestational age with CIMT in children. SMD in CIMT between children born with a small size for gestational age (exposed) and
those born with an appropriate size for gestational age (reference) in (A) all studies or (B) studies at higher CIMT reliability. Weights are from random-effects model. A
positive SMD corresponds to a higher CIMT in the exposed as opposed to reference. CI, confidence interval; CIMT, carotid-intima media thickness; N, sample size; p, p-
value; SMD, standardized mean difference.
https://doi.org/10.1371/journal.pmed.1003414.g002
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blood pressure, total cholesterol, or glucose levels), but also via direct effects on the vessels
structure and function. Assessing the relationship with carotid remodeling already in children
was needed to shed light on the consistency and magnitude of associations, their clinical and
public health importance, as well as to provide suggestions for mechanisms that need to be
addressed in subsequent high-quality studies. Given that atherosclerosis is a disease affecting
the whole arterial system, similar research efforts focusing on the aortic bed are currently
underway (PROSPERO; CRD42019137559).
The relationship of impaired fetal growth with a higher CVD risk in later life was among
the first one to be reported in the DOHaD literature. Systematic reviews and meta-analyses in
adults showed that a low birth weight is associated with an increased risk of elevated blood
pressure and coronary heart disease [90]. Other studies found evidence of a thicker CIMT in
young adults with a small size at birth [8,9]. We found a thicker CIMT in children that were
born small for gestational age, with a stronger relationship in infants than in older children.
This finding is in line with previous studies and indicates that fetal growth restriction may
place the individual on a higher risk trajectory since birth. It has been argued that the defini-
tion of small for gestational age may not distinguish infants that are born small due to an intra-
uterine pathologic process from those that have reached their genetic potential but are
constitutionally small [91]. Further, fetal growth restriction was shown to be associated with
cardiac remodeling and reduced arterial compliance already in utero [92]; therefore, the sever-
ity of the growth impairment might play a key role in the vascular abnormalities of these chil-
dren. Following this reasoning, we restricted our analyses to children that were born small for
Fig 3. Association of prematurity with CIMT in children. SMD in CIMT between children born preterm (exposed)
and those born at term (reference) in (A) all studies or (B) studies at higher CIMT reliability. Weights are from
random-effects model. A positive SMD corresponds to a higher CIMT in the exposed as opposed to reference. CI,
confidence interval; CIMT, carotid-intima media thickness; N, sample size; p, p-value; SMD, standardized mean
difference.
https://doi.org/10.1371/journal.pmed.1003414.g003
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Table 4. Subgroup meta-analyses of SMD for the association of small size for gestational age or prematurity with CIMT.
Birth size for gestational age (small vs appropriate) Gestational age (preterm vs term)
N studies SMD I2, tau2� p† N studies SMD I2, tau2� p†
All 16 0.40 (95% CI: 0.15 to 0.64, p:
0.001)
83%,
0.18
- 7 0.03 (95% CI: −0.17 to 0.22, p:
0.805)
50%,
0.03
-
Study design
Cohort 7 0.39 (95% CI: 0 to 0.78, p: 0.049) 79%, 0.2 0.528 5 0.1 (95% CI: −0.13 to 0.33, p:
0.383)
45%,
0.03
0.030
Cross-sectional 9 0.41 (95% CI: 0.07 to 0.74, p:
0.017)
87%,
0.21
2 −0.18 (95% CI: −0.39 to 0.04, p:
0.104)
0%, 0
Study setting
Community or population
based
1 −0.09 (95% CI: −0.30 to 0.13, p:
0.440)
- <0.001 3 0.08 (95% CI: −0.23 to 0.38, p:
0.626)
73%,
0.05
0.716
Healthcare facility 13 0.43 (95% CI: 0.14 to 0.72, p:
0.004)
83%,
0.21
4 −0.04 (95% CI: −0.34 to 0.27, p:
0.816)
32%,
0.03
N/S 2 0.60 (95% CI: 0.36 to 0.85, p:
<0.001)
1%, 0.00 - - -
CIMT wall
Far 11 0.38 (95% CI: 0.11 to 0.64, p:
0.005)
82%,
0.15
0.756 6 0.08 (95% CI: −0.11 to 0.27, p:
0.425)
42%,
0.02
0.066
N/S 5 0.47 (95% CI: −0.17 to 1.12, p:
0.149)
88%,
0.46
1 −0.37 (95% CI: −0.81 to 0.06, p:
0.090)
-
CIMT sides
Left and right 12 0.5 (95% CI: 0.22 to 0.79, p: 0.001) 84%,
0.19
0.196 4 0.02 (95% CI: −0.2 to 0.23, p:
0.889)
41%,
0.02
0.059
Right 2 0 (95% CI: −0.35 to 0.35, p: 1.000) 0%, 0.00 1 0.35 (95% CI: 0.01 to 0.69, p: 0.045) -
N/S 2 0.11 (95% CI: −1.00 to 1.21, p:
0.849)
95%,
0.60
2 −0.22 (95% CI: −0.6 to 0.17, p:
0.272)
19%,
0.02
CIMT edge detection method
Automatic or semiautomatic 4 0.35 (95% CI: 0.04 to 0.67, p:
0.029)
69%,
0.06
<0.001 3 0.21 (95% CI: 0.03 to 0.39, p: 0.021) 0%, 0 0.006
Manual 6 0.22 (95% CI: −0.26 to 0.71, p:
0.367)
88%,
0.31
2 −0.23 (95% CI: −0.43 to −0.03, p:
0.025)
0%, 0
N/S 6 0.64 (95% CI: 0.27 to 1.01, p:
0.001)
71%,
0.14
2 −0.02 (95% CI: −0.46 to 0.43, p:
0.949)
0%, 0
Ultrasound transducer frequency
�12 MHz 10 0.69 (95% CI: 0.45 to 0.93, p:
<0.001)
57%,
0.07
<0.001 3 0.21 (95% CI: −0.06 to 0.48, p:
0.123)
0%, 0 0.253
>12 MHz 4 0.03 (95% CI: −0.5 to 0.56, p:
0.904)
90%,
0.26
2 −0.06 (95% CI: −0.66 to 0.54, p:
0.846)
77%,
0.14
N/S 2 −0.06 (95% CI: −0.25 to 0.12, p:
0.505)
0%, 0.00 2 −0.04 (95% CI: −0.34 to 0.27, p:
0.808)
69%,
0.03
Age
0 to 1 years 4 0.63 (95% CI: −0.02 to 1.27, p:
0.057)
91%,
0.39
0.002 1 0.03 (95% CI: −0.53 to 0.59, p:
0.924)
- 0.957
2 to 16 years 12 0.31 (95% CI: 0.06 to 0.55, p:
0.014)
77%,
0.13
6 0.02 (95% CI: −0.2 to 0.25, p:
0.828)
58%,
0.04
N participants
<200 11 0.44 (95% CI: 0.05 to 0.84, p:
0.027)
83%,
0.35
0.699 4 −0.04 (95% CI: −0.34 to 0.27, p:
0.816)
32%,
0.03
0.716
�200 5 0.34 (95% CI: 0.03 to 0.65, p:
0.034)
86%,
0.11
3 0.08 (95% CI: −0.23 to 0.38, p:
0.626)
73%,
0.05
�I2 and tau2 assess within-group heterogeneity.
†p-value assesses between-group heterogeneity.
CI, confidence interval; CIMT, carotid intima-media thickness; N, number; N/S, not specified; p, p-value; SMD, standardized mean difference.
https://doi.org/10.1371/journal.pmed.1003414.t004
PLOS MEDICINE Cardiovascular risk factors in the first 1,000 days of life
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003414 November 23, 2020 18 / 29
gestational age and had a documented prenatal diagnosis of IUGR. CIMT remained thicker in
IUGR children compared with those born appropriate for gestational age (Table 3). Also, the
vast majority of included studies used Doppler velocimetry in the maternal or fetal vessels to
diagnose IUGR; thus, these findings support the role of a well-characterized mechanism of vas-
cular remodeling after poor fetal growth, namely the placental dysfunction [10].
The duration of gestation, maternal diabetes, or parental smoking during pregnancy are
known determinants of the size at birth [1] and may also directly affect the vascular function
and structure. Prematurity was shown to increase the risk of hypertension in adolescents and
adults [93], probably through impaired renal development. Young adults that were born pre-
term were shown to have a slightly higher CIMT, noted in 3 of 4 studies of a recent systematic
review and meta-analysis [94]. We did not find consistent evidence of a relationship between
prematurity and higher CIMT in children. This may be because prematurity is more likely to
be associated with a higher cardiovascular risk only if accompanied by fetal growth restriction
or higher blood pressure in later life [8,95]. Also, it may be due to the measurement error in
CIMT. In our case, it is plausible to be a combination of these mechanisms, as studies meta-
Fig 4. Association of (A) ART conception, (B) maternal diabetes in pregnancy, and (C) maternal smoking in
pregnancy with CIMT in children. SMD in CIMT between children: (A) conceived through ART (exposed) or
naturally (reference); (B) exposed to maternal diabetes during pregnancy (exposed) or not exposed (reference); and
(C) exposed to maternal smoking during pregnancy (exposed) or not exposed (reference). Weights are from random-
effects model. A positive SMD corresponds to a higher CIMT in the exposed as opposed to reference. ART, assisted
reproductive technologies; CI, confidence interval; CIMT, carotid-intima media thickness; N, sample size; p, p-value;
SMD, standardized mean difference.
https://doi.org/10.1371/journal.pmed.1003414.g004
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analyzed involved former preterm children, with or without poor fetal growth; therefore, a dis-
tortion of this association cannot be excluded, and CIMT was higher when restricted to studies
with more reliable measurements. Of note, the relationship of CIMT with prematurity was
weaker than that with small for gestational age, which pleads for a greater impact of the latter,
and potentially, a more pronounced impact when the 2 risk factors are present concomitantly.
Interestingly, we found inverse, but very weak, relationships of CIMT with other growth indi-
cators, such as birth length, potentially because they do not account for the duration of gesta-
tion. We also found no clear evidence of a higher CIMT after exposure to maternal diabetes
during pregnancy and a consistently higher CIMT, although of very low magnitude, in chil-
dren exposed to maternal smoking during pregnancy. It is known that gestational diabetes is
associated with macrosomia in the offspring, whereas maternal smoking during pregnancy is
associated with poor fetal growth [1]. Our data indicate that CIMT was consistently increased
in children with abnormal growth, either large or small. The effect of maternal gestational dia-
betes or smoking may thus be mainly indirect, through the size at birth. However, adequately
powered studies that formally assess the mediator effect of size at birth on these relationships
are needed to shed light on this hypothesis [96]. Finally, our finding of a higher CIMT in chil-
dren conceived through ART draws attention on the highly sensitive periconceptional period,
with potentially new underlying mechanisms that need to be disentangled.
Heterogeneity and poorly reported or missing information on key characteristics of the
CIMT measurement methods were among the main issues that we encountered when analyz-
ing the evidence presented herein. Similar conclusions were drawn in systematic reviews on
CIMT in adults that carefully considered measurement methods when interpreting their
results [6,97]. In our case, the sensitivity analyses performed for small size for gestational age
and prematurity showed that the quality of CIMT measurement methods had a significant
impact on the results. Additionally, CIMT values may differ with the edge detection method
and the specificities of the ultrasound equipment used, such as the transducer frequency. We
could notice large decreases in the magnitude of association estimates across studies using
higher transducer frequencies. Our finding is in line with other evidence showing that conven-
tional high frequencies (�12 MHz) may have insufficient ultrasound resolution and result in
an overestimation of the true thickness in children under 12 years of age [18,19]. Novel tech-
niques that measure CIMT with very high-resolution ultrasound (25 to 55 MHz) seem to be
more precise in infants and young children and at very early stages of atherosclerosis [98,99].
Strengths and limitations
The strength of our systematic review lies primarily in the fact that it was performed according
to a detailed protocol that was prospectively registered on PROSPERO and published in full in
a peer-reviewed journal. Secondly, we collected extensive data on the CIMT measurement
characteristics, which permitted interpretation of results in the light of the quality of measure-
ment. Thirdly, we included both observational and interventional studies reporting on expo-
sures or interventions at the child, family, or environmental levels. This helped us have a
comprehensive overview on the current status of the evidence and highlight needed areas of
future research.
The main limitation is that the body of evidence for this systematic review is largely obser-
vational, which is of low certainty by design and restricts the ability to draw conclusions about
causality. Additionally, the degree of confidence in results is limited by the high between-study
heterogeneity. Studies varied on several aspects, such as design, exposure metric, age at CIMT
assessment, or CIMT image analysis. The variability in age at CIMT assessment was large,
from 0 to 18 years. Our subgroup analysis was mainly based on the age range reported in each
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study and, thus, could only distinguish the infants from the other pediatric age groups com-
bined. Meta-analyses were performed mainly using estimates from bivariate associations. Data
transformation and simplification were needed, and associations were estimated from various
statistics so that relationships could be summarized in a consistent way across studies. There-
fore, differences in body size between exposed and nonexposed could not be taken into
account in the analyses, confounding bias cannot be excluded, and our association estimates
may be distorted, probably underestimated, due to measurement error in the CIMT. Further-
more, CIMT was evaluated in youth with tiny, submillimetric vessel structures, and many
studies had relatively small samples and few individuals exposed to the risk factors of interest,
which resulted in large CIs for the estimates. The low number of studies meta-analyzed often
impeded conduction of subgroup analyses to explore the sources of heterogeneity predefined
in the protocol. However, to increase our confidence in the overall estimates, whenever possi-
ble, we conducted analyses restricted to studies at higher quality for all CIMT reliability
domains. Other limitations are represented by exclusion of studies not reported in English or
French [100–102], publication bias, and selective exposure or analysis reporting. Usable data
for the majority of exposures or interventions were reported by a low to a very low number of
studies. However, for small size for gestational age, the risk factor most studied, the funnel plot
inspection, and Egger test were not indicative of publication bias (S2 Fig).
Implications for research and practice
We highlight the need of a standardized ultrasound protocol for measuring CIMT in children.
Due to the paucity of interventional studies and the limited quality of CIMT measurements,
further high-quality studies are needed to justify the use of CIMT for child CVD risk assess-
ment in clinical practice. However, promotion of a healthy lifestyle is important at any age,
and screening of postnatal CVD factors, such as hypertension or obesity, targeted at children
exposed to risk factors in the first 1,000 days of life, may be warranted.
Further, our study indicated that children that were small for gestational age had a higher
CIMT in early life. Prevention of small for gestational age could have a big impact from a public
health perspective. Its prevalence varies among populations and rises with decreasing gestational
age and availability of resources, reaching about 20% in low and middle-income countries [103].
Moreover, modifiable factors, including gestational smoking or poor maternal nutrition, account
for a large share of small for gestational age infants [104]. In fact, smoking cessation interventions
during pregnancy were shown to result in a 17% reduction in low birth weight cases [105]. Public
health strategies to reduce smoking and improve the nutritional status in women of reproductive
age should be advocated and may improve the cardiovascular health too [105,106].
Conclusions
In our meta-analyses, we found several risk factors in the first 1,000 days of life that may be
associated with increased CIMT in infants, children, and adolescents. Poor fetal growth had
the most consistent and strongest association with increased CIMT. The associations with
ART conception or with maternal smoking during pregnancy were not statistically significant.
From a DOHaD perspective, exposure to adverse experiences in early life determines adapta-
tive responses in the organs’ structure and function with lifelong effects on cardiovascular
health and disease, ranging from elevated blood pressure, early vascular aging and increased
CIMT, and premature CVD morbidity and mortality [1,107]. Therefore, assessing CIMT early
in life is important to distinguish between changes occurring in childhood and adulthood,
with the goal of better characterizing lifetime risk trajectories. Provided this hypothesis will
stand the test of time and effective intervention, the interplay of risk factors in the first 1,000
PLOS MEDICINE Cardiovascular risk factors in the first 1,000 days of life
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003414 November 23, 2020 21 / 29
days of life and vascular remodeling will offer a great opportunity for primordial prevention of
CVD [108].
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prenatal growth restraint and post-natal catch-up growth leads to a thicker intima-media and more pre-
peritoneal and hepatic fat by age 3–6 years. Pediatr Obes. 2016; 11(4):251–257. https://doi.org/10.
1111/ijpo.12053 PMID: 26132470
65. Liu RS, Mensah FK, Carlin J, Edwards B, Ranganathan S, Cheung M, et al. Socioeconomic Position
Is Associated With Carotid Intima-Media Thickness in Mid-Childhood: The Longitudinal Study of Aus-
tralian Children. J Am Heart Assoc. 2017; 6(8). https://doi.org/10.1161/jaha.117.005925 PMID:
28862928
66. Mohlkert LA, Hallberg J, Broberg O, Hellström M, Pegelow Halvorsen C, Sjöberg G, et al. Preterm
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